VYGR
Voyager Therapeutics Inc
2.50$
+0.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -202.9% | – | – | – | -298.7% | – | – | – | -119.6% | – | |
| – | – | +226.1% | +2.0% | +160.6% | +32.7% | +30.6% | +38.0% | +35.3% | +19.9% | -28.3% | +6.5% | -14.2% | |
| – | – | +847.5% | +56.7% | +46.4% | +70.1% | -0.4% | -4.5% | -24.2% | -17.5% | +19.4% | +32.6% | +0.0% | |
| – | – | +448.1% | -45.3% | +5.4% | +76.8% | -15.3% | +6.5% | -24.2% | -14.2% | – | – | – | |
| – | +162.1% | +11,669.8% | -122.9% | – | – | +41.6% | -284.3% | – | +521.5% | -425.1% | – | -182.5% | |
| – | – | -65.5% | +388.3% | -20.8% | +8.0% | +79.3% | +56.7% | -86.7% | +54.8% | +30.7% | +8.1% | -26.3% | |
| – | – | +5,798.5% | – | -107.8% | – | -441.8% | – | -41.7% | -111.1% | +1,830.0% | -33.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +130,886.3% | -99.5% | +9.5% | +52.8% | -22.9% | +27.3% | -30.8% | -17.6% | – | – | – | |
| – | +286.7% | +703.5% | -99.7% | +11,557.6% | -92.1% | +1,605.5% | -96.1% | -80.7% | +81.4% | +2,931.1% | +238.9% | -99.3% | |
| – | +2,455.6% | +251.8% | -78.0% | -195.9% | – | +155.6% | -53.0% | -29.4% | -242.2% | – | – | -261.3% | |
| – | – | – | -218.0% | – | – | – | -365.7% | – | – | – | -125.2% | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.